| Dr Ikemefuna Akusoba, MD | |
|
240 Cetronia Rd Ste 205n, Allentown, PA 18104 | |
| (484) 426-2600 | |
| (833) 816-7512 |
| Full Name | Dr Ikemefuna Akusoba |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 12 Years |
| Location | 240 Cetronia Rd Ste 205n, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740544998 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD455576 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
| St Lukes Warren Physician Group Pc | 9739093675 | 314 |
News Archive
The promise of stem cells seems limitless. If they can be coaxed into rebuilding organs, repairing damaged spinal cords and restoring ravaged immune systems, these malleable cells would revolutionize medical treatment. But stem cell research is still in its infancy, as scientists seek to better understand the role of these cells in normal human development and disease.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
House Republican lawmakers are questioning hiring practices at the Department of Health and Human Services as well as how the Internal Revenue Service will enforce provisions of the health law.
The corticosteroid budesonide shows promise in treating patients with mild COVID-19 infection. Interim analysis of the phase 3 PRINCIPLE clinical trial was posted to the medRxiv preprint server. Researchers found a 3-day faster recovery of COVID-19 symptoms in people at high risk for severe side effects administered a budesonide inhaler. There was also a 2.1% reduction in hospitalization and death.
› Verified 8 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
The promise of stem cells seems limitless. If they can be coaxed into rebuilding organs, repairing damaged spinal cords and restoring ravaged immune systems, these malleable cells would revolutionize medical treatment. But stem cell research is still in its infancy, as scientists seek to better understand the role of these cells in normal human development and disease.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
House Republican lawmakers are questioning hiring practices at the Department of Health and Human Services as well as how the Internal Revenue Service will enforce provisions of the health law.
The corticosteroid budesonide shows promise in treating patients with mild COVID-19 infection. Interim analysis of the phase 3 PRINCIPLE clinical trial was posted to the medRxiv preprint server. Researchers found a 3-day faster recovery of COVID-19 symptoms in people at high risk for severe side effects administered a budesonide inhaler. There was also a 2.1% reduction in hospitalization and death.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ikemefuna Akusoba, MD 240 Cetronia Rd Ste 205n, Allentown, PA 18104-9263 Ph: (484) 426-2600 | Dr Ikemefuna Akusoba, MD 240 Cetronia Rd Ste 205n, Allentown, PA 18104 Ph: (484) 426-2600 |
News Archive
The promise of stem cells seems limitless. If they can be coaxed into rebuilding organs, repairing damaged spinal cords and restoring ravaged immune systems, these malleable cells would revolutionize medical treatment. But stem cell research is still in its infancy, as scientists seek to better understand the role of these cells in normal human development and disease.
Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.
House Republican lawmakers are questioning hiring practices at the Department of Health and Human Services as well as how the Internal Revenue Service will enforce provisions of the health law.
The corticosteroid budesonide shows promise in treating patients with mild COVID-19 infection. Interim analysis of the phase 3 PRINCIPLE clinical trial was posted to the medRxiv preprint server. Researchers found a 3-day faster recovery of COVID-19 symptoms in people at high risk for severe side effects administered a budesonide inhaler. There was also a 2.1% reduction in hospitalization and death.
› Verified 8 days ago
Robert D Barraco, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Suite 308, Allentown, PA 18103 Phone: 610-402-1350 Fax: 610-402-1356 | |
Rovinder Singh Sandhu, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-1350 | |
Dr. Daniel Ryan Latta, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-482-8000 | |
Heiwon Chung, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1240 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-402-7884 | |
Heather Lynn Geist, MD Surgery Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Dr. Marissa Lynn Dallara, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
William D Hardin Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1259 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-1259 |